Webinar

Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients

Now Available On Demand

Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least two distinct types of cytokine signatures induced by SARS-CoV-2 infection. At time of hospitalization, COVID-19 patients with severe respiratory disease present low viremia and a dominant pro-inflammatory response.

In contrast, less severe patients have a high viral load and elevated type-I interferon levels. Nevertheless, a strong antiviral interferon response is not always beneficial. Importantly, the risk of death was associated with the intensity of the cytokine signatures characterizing each severity group. These findings call for a personalized approach to successfully treat COVID-19 patients.

Attend this webinar to:
  • Learn about recently published observations that describe distinct cytokine profiles and COVID-19 severity and mortality
  • Discuss the need for personalized precision medicine approach to successfully treat COVID-19 patients
  • Explore the ultra-sensitive biomarker detection technologies that enabled these findings

Speaker Information:

Guy Gorochov, MD, Ph.D
Professor of Medicine, Head of the Department of Immunology and Co-Director CIMI Research Centre
Sorbonne University/INSERM

WebinarSpeakerImage-(003) Kevin
Kevin Hrusovsky
CEO and Chairman
Quanterix Corporation

Laurel Provencher
Senior Director, Strategic Collaborations
Quanterix Corporation

Attend this webinar to:

  • Learn about recently published observations that describe distinct cytokine profiles and COVID-19 severity and mortality
  • Discuss the need for personalized precision medicine approach to successfully treat COVID-19 patients
  • Explore the ultra-sensitive biomarker detection technologies that enabled these findings

Watch for FREE Now!